EXPE vs IONS · P/E 20, rev $7.74B vs rev $514.0M
Expedia Group Inc. (EXPE) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. IONS currently screens at market cap $12.28B.
Not investment advice. Open the EXPE and IONS stock pages for the full models.
Not investment advice.